All guides

The Science · 3 min read

How GLP-1 Medications Actually Work

No jargon, no hype — just a clear explanation of what GLP-1 is, what it does in three places in your body, and why that adds up to less hunger and more control.

Download as PDF
Illustration of how GLP-1 works in the body

GLP-1 (glucagon-like peptide-1) is a hormone your gut releases after you eat. It tells your brain you’re full, slows how fast your stomach empties, and helps steady your blood sugar. GLP-1 medications extend that natural signal.

Three places it works at once

1

Your brain — quiets appetite

It strengthens the fullness signal to your brain, so cravings and constant “food noise” fade and you naturally want less.

2

Your stomach — slows digestion

Food stays in your stomach longer, so you feel satisfied for hours on smaller portions.

3

Your metabolism — steadies blood sugar

It supports a healthy insulin response, smoothing the spikes and crashes that drive hunger.

Why that matters for weight loss

Most diets fail because they rely on willpower against a hunger signal that never lets up. By turning down that signal at the source, GLP-1 medications make eating less feel less like a fight. That’s why clinical trials of these medication classes showed substantially greater average weight loss than diet and exercise alone.

14.9%

Avg. loss — semaglutide (NEJM STEP-1)

20.9%

Avg. loss — tirzepatide (NEJM SURMOUNT-1)

2.4%

Avg. loss — diet & exercise alone

It works best as part of a plan

Medication is one lever. AvataCore plans pair it with provider supervision and care-team check-ins so the habits, dose, and results move together.

See if you qualify

A licensed U.S. provider reviews every intake. No card required. Plans start at $149 for your first 4 weeks.

Take the 2-minute quiz →

No card required · Same-day provider review · Cancel anytime

Important: This content is for educational purposes only and is not medical advice. Compounded medications are NOT FDA-approved and are different from FDA-approved branded products such as Ozempic®, Wegovy®, Zepbound®, and Mounjaro®. They are prepared by licensed U.S. pharmacies under 503A regulation and have not been evaluated by the FDA for safety, efficacy, or quality. AvataCore is not affiliated with Novo Nordisk or Eli Lilly. Individual results vary. Eligibility for treatment is determined by a licensed provider. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly.